ResMed (RMD)

NYSE Health Care Health Care Equipment S&P 500
$235.30
-4.01 (-1.68%)
Close of Nov 06, 2026 · end-of-day data
Source: ResMed's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue$2.07B$2.34B$2.61B$2.96B$3.20B$3.58B$4.22B$4.69B$5.15B$5.65B
Cost of revenue$864.99M$1.01B$1.11B$1.24B$1.36B$1.55B$1.87B$2.03B$2.09B$2.20B
Gross profit$1.20B$1.33B$1.49B$1.72B$1.84B$2.02B$2.36B$2.66B$3.05B$3.45B
Research & development$144.47M$155.15M$180.65M$201.95M$225.28M$253.57M$287.64M$307.52M$331.28M$378.29M
Selling, general & admin$553.97M$600.37M$645.01M$676.69M$670.39M$737.51M$874.00M$917.14M$993.05M$1.12B
Operating income$425.80M$541.83M$579.26M$809.66M$903.68M$1.00B$1.13B$1.32B$1.69B$1.89B
Interest expense$28.24M$28.36M$36.16M$40.38M$23.99M—————
Pre-tax income$418.74M$521.31M$518.85M$733.09M$883.66M$960.48M$1.10B$1.26B$1.68B$1.92B
Income tax$76.46M$205.72M$114.25M$111.41M$409.16M$181.05M$204.11M$243.85M$276.84M$396.12M
Net income$342.28M$315.59M$404.59M$621.67M$474.50M$779.44M$897.56M$1.02B$1.40B$1.52B
EBITDA$537.96M$661.79M$730.06M$964.51M$1.06B$1.16B$1.30B$1.50B$1.88B$2.09B
EPS (basic)$2.42$2.21$2.83$4.31$3.27$5.34$6.12$6.94$9.55$10.47
EPS (diluted)$2.40$2.19$2.80$4.27$3.24$5.30$6.09$6.92$9.51$10.43
Diluted shares142.45M143.99M144.48M145.65M146.45M147.04M147.46M147.55M147.34M146.05M
Gross margin58.1%57.0%57.3%58.1%57.5%56.6%55.8%56.7%59.4%61.1%
Operating margin20.6%23.2%22.2%27.4%28.3%28.0%26.8%28.2%32.7%33.4%
Net margin16.6%13.5%15.5%21.0%14.8%21.8%21.3%21.8%27.2%26.9%

Balance sheet

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash & equivalents$821.93M$188.70M$147.13M$463.16M$295.28M$273.71M$227.89M$238.36M$1.21B$1.47B
Receivables$450.53M$483.68M$528.48M$474.64M$614.29M$575.95M$704.91M$837.27M$939.49M$1.04B
Inventory$268.32M$268.70M$349.64M$416.92M$457.03M$743.91M$998.01M$822.25M$927.71M$945.80M
Total current assets$1.64B$1.07B$1.15B$1.52B$1.57B$1.93B$2.37B$2.36B$3.51B$4.32B
Goodwill$1.06B$1.07B$1.86B$1.89B$1.93B$1.94B$2.77B$2.84B$3.05B$2.91B
Total assets$3.47B$3.06B$4.11B$4.59B$4.73B$5.10B$6.75B$6.87B$8.17B$8.97B
Total current liabilities$360.13M$511.25M$555.99M$602.76M$911.77M$689.30M$758.53M$910.65M$1.02B$1.40B
Short-term debt—$11.47M$11.99M$11.99M$12.00M$9.92M$9.90M$9.90M$9.90M$259.95M
Long-term debt$1.08B$269.99M$1.26B$1.16B$643.35M$765.33M$1.43B$697.31M$658.39M$399.42M
Total debt$1.08B$281.45M$1.27B$1.18B$655.35M$775.24M$1.44B$707.21M$668.29M$659.37M
Total liabilities$1.51B$1.00B$2.04B$2.09B$1.84B$1.74B$2.62B$2.01B$2.21B$2.38B
Shareholders' equity$1.96B$2.06B$2.07B$2.50B$2.89B$3.36B$4.13B$4.86B$5.97B$6.59B

Cash flow

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow$414.05M$505.03M$459.05M$802.25M$736.72M$351.15M$693.30M$1.40B$1.75B$1.81B
Capital expenditures$62.22M$62.58M$68.71M$95.33M$102.71M$134.84M$119.67M$99.46M$89.86M$156.28M
Free cash flow$351.83M$442.44M$390.34M$706.92M$634.01M$216.31M$573.63M$1.30B$1.66B$1.65B
Investing cash flow-$81.89M-$101.82M-$1.08B-$179.86M-$158.46M-$229.92M-$1.16B-$269.78M-$200.04M-$545.20M
Financing cash flow-$262.87M-$1.03B$580.64M-$317.29M-$764.63M-$128.36M$422.87M-$1.12B-$606.25M-$1.01B
Dividends paid$186.35M$199.50M$211.71M$225.09M$226.71M$245.34M$258.28M$282.32M$310.88M$349.66M
Share buybacks—$53.80M$22.84M——$0$0$150.01M$300.02M$700.04M
Stock-based compensation$45.92M$48.41M$52.07M$57.56M$63.93M$65.26M$71.14M$80.18M$91.66M$104.35M
Depreciation & amortization$112.16M$119.96M$150.79M$154.85M$156.76M$159.61M$165.16M$176.87M$198.47M$201.34M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.